Selective Serotonin Reuptake Inhibitors (SSRI) Pathway (2009)

Peer-Reviewed Study · Sangkuhl K, Klein TE, Altman RB · November 2009

Sangkuhl K et al., 2009-11: Peer-reviewed pathway review states SSRIs bind the serotonin uptake transporter with high affinity and have very low affinity for neurotransmitter receptors – the opposite of jamming receptors.

SSRI have a high affinity for 5-HT uptake transporters, low affinity for noradrenaline uptake transporters, and very low affinity for neurotransmitter receptors.

Sangkuhl K et al., 2009-11: Peer-reviewed pathway review states SSRIs bind the serotonin uptake transporter with high affinity and have very low affinity for neurotransmitter receptors – the opposite of jamming receptors. Pharmacogenetics and Genomics 2009;19(11):907-9; PMC author manuscript. Type: review (PharmGKB pathway). No patients. Funder/conflicts: not stated in the PMC text retrieved. Note the same article contains a typographic error 'SCL6A4' where SLC6A4 is meant. Study type: review.